D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 57 Citations 11,150 211 World Ranking 6539 National Ranking 141

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Cancer
  • Enzyme

Her primary areas of investigation include Molecular biology, Antibody, Antigen, Monoclonal antibody and Cell culture. She combines subjects such as Cytotoxic T cell, In vitro, Matrigel, Biochemistry and Folate receptor with her study of Molecular biology. Her Antibody research is multidisciplinary, incorporating elements of Proportional hazards model, Tissue microarray, Disease and Fisher's exact test.

Her Antigen research is multidisciplinary, relying on both Immunogen, Beta, Cytotoxicity and Immunotherapy. Silvana Canevari usually deals with Monoclonal antibody and limits it to topics linked to Immunofluorescence and Ovarian tumor and Cell membrane. She has included themes like Cell, Cell growth, Cancer stem cell, Side population and CD3 in her Cell culture study.

Her most cited work include:

  • A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer (856 citations)
  • Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity (336 citations)
  • Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. (233 citations)

What are the main themes of her work throughout her whole career to date?

Her primary scientific interests are in Cancer research, Monoclonal antibody, Molecular biology, Internal medicine and Immunology. Within one scientific family, Silvana Canevari focuses on topics pertaining to Pathology under Cancer research, and may sometimes address concerns connected to Breast cancer. Her Monoclonal antibody research is classified as research in Antibody.

In her study, In vitro is inextricably linked to In vivo, which falls within the broad field of Antibody. Her research in Molecular biology intersects with topics in Cell culture, Cell, Biochemistry and Folate receptor. Her Internal medicine research incorporates themes from Endocrinology and Oncology.

She most often published in these fields:

  • Cancer research (31.66%)
  • Monoclonal antibody (27.59%)
  • Molecular biology (23.51%)

What were the highlights of her more recent work (between 2011-2021)?

  • Internal medicine (20.38%)
  • Cancer research (31.66%)
  • Oncology (14.42%)

In recent papers she was focusing on the following fields of study:

Internal medicine, Cancer research, Oncology, Ovarian cancer and Pathology are her primary areas of study. Her Internal medicine research is multidisciplinary, incorporating perspectives in microRNA and Immunology. Her work carried out in the field of Cancer research brings together such families of science as Cell growth, Molecular medicine, Cancer cell, Receptor tyrosine kinase and Antibody.

Her Antibody study focuses on Monoclonal antibody in particular. Her research on Ovarian cancer also deals with topics like

  • Tissue microarray together with Grading, Ovarian carcinoma and Serous fluid,
  • Tumor progression and related Protein kinase B and PI3K/AKT/mTOR pathway. Silvana Canevari works mostly in the field of Pathology, limiting it down to concerns involving In vivo and, occasionally, Apoptosis.

Between 2011 and 2021, her most popular works were:

  • Targeting folate receptor alpha for cancer treatment. (154 citations)
  • Targeting the Folate Receptor: Diagnostic and therapeutic approaches to personalize cancer treatments (132 citations)
  • Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data (81 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Enzyme

Silvana Canevari mostly deals with Cancer research, Ovarian cancer, Internal medicine, Cancer and Oncology. Her studies deal with areas such as Cell growth, Cancer cell, Folate Receptor Alpha, Mitosis and Receptor tyrosine kinase as well as Cancer research. Her Ovarian cancer study incorporates themes from Choline, Choline kinase, Pathology, Phosphocholine and Adenocarcinoma.

Her Internal medicine research incorporates elements of Biological target and Endocrinology. Her work deals with themes such as Monoclonal antibody and Bioinformatics, which intersect with Cancer. As a part of the same scientific study, she usually deals with the Monoclonal antibody, concentrating on Prostate cancer and frequently concerns with Molecular biology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

Michael H. Kershaw;Michael H. Kershaw;Michael H. Kershaw;Jennifer A. Westwood;Jennifer A. Westwood;Linda L. Parker;Gang Wang;Gang Wang.
Clinical Cancer Research (2006)

1349 Citations

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity

S. Miotti;S. Canevari;S. Ménard;D. Mezzanzanica.
International Journal of Cancer (1987)

526 Citations

Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.

Sylvie Mènard;Elda Tagliabue;Silvana Canevari;Giuseppe Fossati.
Cancer Research (1983)

352 Citations

Alterations of Choline Phospholipid Metabolism in Ovarian Tumor Progression

Egidio Iorio;Delia Mezzanzanica;Paola Alberti;Francesca Spadaro.
Cancer Research (2005)

346 Citations

Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody.

Silvana Canevari;Gerrit Stoter;Flavio Arienti;Giorgio Bolis.
Journal of the National Cancer Institute (1995)

266 Citations

Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland

E G Bremer;S B Levery;S Sonnino;R Ghidoni.
Journal of Biological Chemistry (1984)

263 Citations

Targeting folate receptor alpha for cancer treatment.

Anthony Cheung;Heather J. Bax;Debra H. Josephs;Kristina M. Ilieva.
Oncotarget (2016)

207 Citations

Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro.

V Dolo;S D'Ascenzo;S Violini;L Pompucci.
Clinical & Experimental Metastasis (1999)

192 Citations

Targeting the Folate Receptor: Diagnostic and therapeutic approaches to personalize cancer treatments

J. A. Ledermann;Silvana Canevari;T. Thigpen.
Annals of Oncology (2015)

192 Citations

Activation of Phosphatidylcholine Cycle Enzymes in Human Epithelial Ovarian Cancer Cells

Egidio Iorio;Alessandro Ricci;Marina Bagnoli;Maria Elena Pisanu.
Cancer Research (2010)

189 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Silvana Canevari

Carl H. June

Carl H. June

University of Pennsylvania

Publications: 53

Sylvie Ménard

Sylvie Ménard

University of Milan

Publications: 48

Maria I. Colnaghi

Maria I. Colnaghi

University of Milan

Publications: 45

Philip S. Low

Philip S. Low

Purdue University West Lafayette

Publications: 39

Phillip K. Darcy

Phillip K. Darcy

Peter MacCallum Cancer Centre

Publications: 31

Michael H. Kershaw

Michael H. Kershaw

Peter MacCallum Cancer Centre

Publications: 30

John Maher

John Maher

King's College London

Publications: 29

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 29

Daniel J. Powell

Daniel J. Powell

University of Pennsylvania

Publications: 27

Hinrich Abken

Hinrich Abken

University of Cologne

Publications: 26

Renier J. Brentjens

Renier J. Brentjens

Memorial Sloan Kettering Cancer Center

Publications: 24

Bruce L. Levine

Bruce L. Levine

University of Pennsylvania

Publications: 23

Gianpietro Dotti

Gianpietro Dotti

University of North Carolina at Chapel Hill

Publications: 22

Malcolm K. Brenner

Malcolm K. Brenner

Baylor College of Medicine

Publications: 22

Antonin de Fougerolles

Antonin de Fougerolles

Alnylam Pharmaceuticals (United States)

Publications: 22

Erika Jensen-Jarolim

Erika Jensen-Jarolim

Medical University of Vienna

Publications: 21

Something went wrong. Please try again later.